Recombinant adeno-associated virus targets passenger gene expression to cones in primate retina

被引:23
|
作者
Mancuso, Katherine
Hendrickson, Anita E.
Connor, Thomas B., Jr.
Mauck, Matthew C.
Kinsella, James J.
Hauswirth, William W.
Neitz, Jay
Neitz, Maureen
机构
[1] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA
[2] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA
[3] Univ Florida, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA
[4] Med Coll Wisconsin, Dept Cell Biol, Milwaukee, WI 53226 USA
[5] Med Coll Wisconsin, Dept Neurobiol & Anat, Milwaukee, WI 53226 USA
[6] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA
关键词
D O I
10.1364/JOSAA.24.001411
中图分类号
O43 [光学];
学科分类号
070207 ; 0803 ;
摘要
Recombinant adeno-associated virus (rAAV) is a promising vector for gene therapy of photoreceptor-based diseases. Previous studies have demonstrated that rAAV serotypes 2 and 5 can transduce both rod and cone photoreceptors in rodents and dogs, and it can target rods, but not cones in primates. Here we report that using a human cone-specific enhancer and promoter to regulate expression of a green fluorescent protein (GFP) reporter gene in an rAAV-5 vector successfully targeted expression of the reporter gene to primate cones, and the time course of GFP expression was able to be monitored in a living animal using the RetCam II digital imaging system. (c) 2007 Optical Society of America.
引用
收藏
页码:1411 / 1416
页数:6
相关论文
共 50 条
  • [31] Recombinant adeno-associated virus as delivery vector for gene therapy - A review
    Lu, Y
    STEM CELLS AND DEVELOPMENT, 2004, 13 (01) : 133 - 145
  • [32] Systemic Toxicity of Recombinant Adeno-Associated Virus Gene Therapy Vectors
    Assaf, Basel T.
    TOXICOLOGIC PATHOLOGY, 2024, 52 (08) : 523 - 530
  • [33] Kinetics of recombinant adeno-associated virus-mediated gene transfer
    Malik, AK
    Monahan, PE
    Allen, DL
    Chen, BG
    Samulski, RJ
    Kurachi, K
    JOURNAL OF VIROLOGY, 2000, 74 (08) : 3555 - 3565
  • [34] Clinical gene therapy using recombinant adeno-associated virus vectors
    Mueller, C.
    Flotte, T. R.
    GENE THERAPY, 2008, 15 (11) : 858 - 863
  • [35] Recombinant adeno-associated virus vectors for cystic fibrosis gene therapy
    Flotte, TR
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2001, 3 (05) : 497 - 502
  • [36] Targeting recombinant adeno-associated virus vectors to enhance gene transfer
    Loiler, SA
    Song, SH
    Warrington, KH
    Agarwal, A
    Kapturczak, M
    Li, CW
    Ricordi, C
    Atkinson, MA
    Muzyczka, N
    Flotte, TR
    PEDIATRIC RESEARCH, 2003, 53 (04) : 133A - 134A
  • [37] Cellular pathways of recombinant adeno-associated virus production for gene therapy
    Sha, Sha
    Maloney, Andrew J.
    Katsikis, Georgios
    Nguyen, Tam N. T.
    Neufeld, Caleb
    Wolfrum, Jacqueline
    Barone, Paul W.
    Springs, Stacy L.
    Manalis, Scott R.
    Sinskey, Anthony J.
    Braatz, Richard D.
    BIOTECHNOLOGY ADVANCES, 2021, 49
  • [38] Orthopaedic gene therapy using recombinant adeno-associated virus vectors
    Ke, J.
    Zheng, L. W.
    Cheung, L. K.
    ARCHIVES OF ORAL BIOLOGY, 2011, 56 (07) : 619 - 628
  • [39] Clinical gene therapy using recombinant adeno-associated virus vectors
    C Mueller
    T R Flotte
    Gene Therapy, 2008, 15 : 858 - 863
  • [40] Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
    Motahareh Arjomandnejad
    Ishani Dasgupta
    Terence R. Flotte
    Allison M. Keeler
    BioDrugs, 2023, 37 : 311 - 329